Both in Biotechnology
Immunovant vs Iovance Biotherapeutics
Over the past year IMVT returned +108.3% and IOVA returned +548.0%; their daily moves had a correlation of 0.26.
IMVT +108.3% IOVA +548.0%Growth of $1, one year, split-adjusted
| Metric | IMVT | IOVA |
|---|---|---|
| Price | $33.46 | $14.45 |
| Market cap | $6.91B | $6.55B |
| Today | −0.09% | +31.48% |
| 1 month | −18.8% | +80.4% |
| 6 months | +42.1% | +335.2% |
| Year to date | +31.6% | +429.3% |
| 1 year | +106.2% | +584.8% |
| Revenue growth (YoY) | — | +65.7% |
| Gross margin | — | 56.1% |
| Net margin | — | −47.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 20.1× |
| Net cash | $797.8M | $297.7M |
| Dividend yield | — | — |
| Volatility (60d) | 35.3% | 119.4% |
| Short % of float | 19.9% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).